Verge Genomics

Nichibei Bio Inc is a biotechnology company based in San Francisco, CA, specializing in research and development in the field of genetic engineering. The company focuses on creating innovative solutions for various industries through the application of cutting-edge biotechnological advancements. Generated from their business information

iBiology Inc is a San Francisco-based organization that produces and evaluates free biology videos, courses, and educator resources for higher education. Their content is designed to engage and educate undergraduate and graduate students, as well as early career scientists and trainees, in various fields of biology. With a focus on promoting scientific understanding and research skills, iBiology aims to bridge the gap between traditional knowledge and modern scientific advancements. Through their diverse range of films, talks, and animations, iBiology explores topics such as microbial worlds, antibiotic resistance, DNA editing, Nobel Prize-winning experiments, and career development in the scientific community. By collaborating with renowned scientists and educators, iBiology provides accessible and informative resources that contribute to the dissemination of biological knowledge and the advancement of scientific research.Generated from the website

Totus Medicines, Inc, based in Emeryville, CA, is dedicated to advancing the field of medicine by targeting previously deemed "undruggable" disease areas. With their innovative high-throughput platform, researchers can now identify drug targets at an unprecedented scale and speed. Utilizing covalent molecules as a key component, Totus Medicines is unlocking new possibilities in drug development, with a focus on addressing poorly treated, advanced forms of cancer. Their robust pipeline of oncology programs aims to revolutionize the treatment landscape for cancer, heart disease, neurodegeneration, and more. Through strategic partnerships and a commitment to groundbreaking research, Totus Medicines is at the forefront of designing life-changing medicines on a genomic scale, with the ultimate goal of saving lives and reshaping the future of healthcare within this decade. Generated from the website content